|
NASHVILLE, Tenn.--(BUSINESS WIRE)--April 25, 2005--Renal Care
Group, Inc. (NYSE: RCI) announced today that Raymond M. Hakim, M.D.,
Ph.D., plans not to renew his employment agreement and resign from his
duties as Senior Executive Vice President of Clinical Affairs and
Chief Medical Officer effective May 30, 2006. Dr. Hakim will work with
the Company to identify and recruit a new Chief Medical Officer.
Speaking at Renal Care Group's annual medical conference this
weekend, Dr. Hakim said, "My tenure at Renal Care Group has been very
productive and rewarding. We have built a company focused on its
mission of improving the quality of life for patients with end stage
renal disease. In identifying a new Chief Medical Officer, we will
look for someone who can provide continuity to what we have been
doing, while bringing new ideas and perspectives. Above all, however,
the new Chief Medical Officer must be someone who will give allegiance
to the most important principle of health care and our work at Renal
Care Group: providing optimal care to the patients we serve."
Gary A. Brukardt, Renal Care Group's President and Chief Executive
Officer, said, "We sincerely thank Dr. Hakim for his tireless efforts
to continuously improve the quality of care for the patients we serve.
He has been with Renal Care Group since it was founded and has
contributed greatly to our success. I am very pleased that Dr. Hakim
has agreed to help us find a new Chief Medical Officer and to assist
in transitioning his successor into the Chief Medical Officer's role."
Renal Care Group will hold its regularly scheduled conference call
to discuss earnings for the quarter ended March 31, 2005 at 11:00
Eastern Daylight Time on Wednesday, May 4, 2005. The Company will
discuss and respond to questions concerning this matter during that
call. A listen-only simulcast, as well as a 12-month replay, of the
conference call to discuss this press release will be available online
at the Company's website at www.renalcaregroup.com.
Renal Care Group, Inc. is a specialized dialysis services company
that provides care to patients with kidney disease. The Company serves
over 30,000 patients at more than 420 outpatient dialysis facilities,
in addition to providing acute dialysis services at more than 210
hospitals. Over 8,900 associates provide services across the Company's
34-state network. More information about Renal Care Group, Inc. may be
found at www.renalcaregroup.com.
Certain statements in this press release, particularly those of
Mr. Brukardt and Dr. Hakim, constitute "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act of
1995. These forward-looking statements, which are usually preceded by
words like expect, plan, intend, believe, will and the like, include
statements that necessarily depend on future events. These
forward-looking statements reflect management's expectations and are
based upon currently available information. These forward-looking
statements involve known and unknown risks, uncertainties and other
factors that may cause actual results, performance or achievements of
Renal Care Group to differ materially from those expressed in or
implied by the forward-looking statements, including risks related to:
the integration of acquired companies; compliance with health care and
other applicable laws; changes in the Medicare and Medicaid programs;
risks related to the drug Epogen (EPO); payment reductions by private
insurers, hospitals or managed care organizations; and changes in the
health care delivery, financing or reimbursement systems. These and
other factors affecting the Company are discussed in more detail in
Renal Care Group's reports filed with the Securities and Exchange
Commission, including without limitation Renal Care Group's most
recent annual report on Form 10-K. Copies of this filing are available
from Renal Care Group upon request.
Contact:
Renal Care Group, Inc.
Terry Proveaux, 615-345-5577
www.renalcaregroup.com
|
Press Releases